glp-1 pen etfe coated plunger Real-World Use of GLP-1s Yields Less Weight Loss Than Clinical Trials Injection Pen for GLP-1 Drug

A head-to-head review of clinical studies determined that among available GLP-1 RAs, there were A1C reductions from 0.78% to 1.9%

Gut microbiota interactions with anti-diabetic medications and pathogenesis of type 2 diabetes mellitus

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated

A handful of recent observational studies have linked GLP-1s to lower cancer risks and/or improved outcomes in cancer survivors, but prospective datathe gold standard in clinical researchis lacking

Two new medications taken by mouth can help trim body weight in people living with obesity, scientists report in two studies published September 16 and 17 in the New England Journal of Medicine